Rasmus Irming Jølck
Corporate Officer/Principal bei Nanovi Radiotherapy A/S
Aktive Positionen von Rasmus Irming Jølck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Corporate Officer/Principal | - | - |
Karriereverlauf von Rasmus Irming Jølck
Ehemalige bekannte Positionen von Rasmus Irming Jølck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Technical University of Denmark | Corporate Officer/Principal | - | 03.11.2014 |
Statistik
International
| Dänemark | 3 |
Operativ
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
- Börse
- Insiders
- Rasmus Irming Jølck
- Erfahrung
